Utilization of Risk Scores for Coronary Heart Disease Diagnosis in Rural China
- PMID: 35282649
- PMCID: PMC8907025
- DOI: 10.2147/IJGM.S355573
Utilization of Risk Scores for Coronary Heart Disease Diagnosis in Rural China
Abstract
Objective: The current study was to design a cardiovascular risk score for the diagnosis of coronary heart disease (CHD) in the rural area of China and the sensitivity and specificity of this score would be assessed.
Methods: A total of 520 patients were enrolled and based on the results from coronary artery angiography, patients were divided into three groups: CHD group (coronary artery ≥50% stenosis), atherosclerosis group (coronary artery <50% stenosis) and normal groups (without stenosis). Between-group differences were evaluated and the sensitivity and specificity of cardiovascular risk score were evaluated.
Results: Compared to the normal and atherosclerosis groups, patients in the CHD group were older, had higher body mass index, and more likely to be smoking and obese, and had dyslipidemia, hypertension and diabetes, and had higher cardiovascular risk score (4.05 ± 2.15 vs 2.94 ± 1.90 vs 2.54 ± 1.59). Patients in the CHD group were more likely to have cardiovascular risk scores ≥2 (90.2% CHD group vs 74.2% atherosclerosis group vs 76.1% normal group, P < 0.05). The area under the ROC was 0.673, with 95% confidence interval was 0.623-0.722 (P < 0.001), and the sensitivity and specificity were highest when the cardiovascular risk score was 4, indicating that the value of cardiovascular risk score of 4 was a good cutoff point for CHD diagnosis.
Conclusion: Using cardiovascular risk score can improve CHD diagnosis which may help to reduce health disparities between rural and urban area.
Keywords: cardiovascular risk score; coronary heart disease; sensitivity; specificity.
© 2022 Liao et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
[Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):588-593. doi: 10.3760/cma.j.issn.2095-4352.2019.05.013. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31198145 Chinese.
-
Changes in plasma levels of RIPK1, RIPK3, and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Sept 28;45(9):1096-1103. doi: 10.11817/j.issn.1672-7347.2020.200026. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33051424 Chinese, English.
-
Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality.Acta Diabetol. 2012 Dec;49 Suppl 1:S65-71. doi: 10.1007/s00592-010-0205-5. Epub 2010 Jul 1. Acta Diabetol. 2012. PMID: 20593206
-
Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.Front Cardiovasc Med. 2021 Jun 21;8:682959. doi: 10.3389/fcvm.2021.682959. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34235188 Free PMC article.
-
Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.Clin Drug Investig. 2007;27(9):591-604. doi: 10.2165/00044011-200727090-00001. Clin Drug Investig. 2007. PMID: 17705568 Review.
References
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327. doi:10.1161/CIR.0b013e31829e8776 - DOI - PubMed
LinkOut - more resources
Full Text Sources